Philips recalled 33 CT systems on August 13, 2025, due to a risk of the patient support table descending unexpectedly. A misalignment in the ball screw can cause the couch to drop to its lowest position. The recall affects models distributed worldwide, including the U.S. and numerous countries.
The patient support table (couch) may descend unexpectedly to the lowermost position due to a component (ball screw) misalignment after a replacement.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Philips North America Llc or your healthcare provider for instructions. Notification method: Letter
The recall includes Philips models: Big Bore RT (Model Number: 728242), Brilliance CT Big Bore Oncology (Model Number: 728243), and Brilliance CT Big Bore (Model Number: 728244). These systems were distributed globally, including the United States and 33 other countries.
The patient support table may descend unexpectedly due to a misalignment in the ball screw component after replacement. This poses a serious risk to patient safety during imaging procedures.
There have been no specific reported injuries or fatalities associated with this defect. However, the potential for harm exists due to the sudden descent of the patient support table.
Stop using the recalled CT systems immediately. Contact Philips North America or your healthcare provider for further instructions and follow the recall process outlined in the notification letter.
For more information, contact Philips North America at 1-800-XXX-XXXX or visit the recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2597-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.